Diagnostics and Biosensing
Nano-enabled platforms for early, accurate, and real-time health monitoring
The Diagnostics and Biosensing theme at the Australian Centre for Nanomedicine (ACN) brings together expertise in nanotechnology, chemistry, materials science, and bioengineering to develop next-generation diagnostic technologies. The focus is on enabling earlier disease detection, real-time monitoring, and more accessible healthcare through innovative sensing platforms.
Research within this theme centres on the development of nano-enabled systems capable of sensitive and selective detection of biomarkers, metabolites, and physiological signals for applications including early cancer detection, infectious disease diagnostics, and chronic disease monitoring. By integrating advances in nanomaterials, surface engineering, and device fabrication, ACN researchers are creating diagnostic tools that are faster, more portable, and more responsive than conventional approaches.
The program spans multiple sensing modalities, including electrochemical, optical, and bioelectronic platforms with integration into wearable and implantable devices for continuous, real-time health monitoring.
Close collaborations with clinicians enable the identification of unmet diagnostic needs and the validation of technologies in real-world healthcare settings, while partnerships with the diagnostics industry support the translation of sensing technologies.
Through these interdisciplinary collaborations, ACN is advancing the development of diagnostic technologies that support precision medicine and improve patient outcomes.
